Kyle Jenne Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kyle Jenne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kyle Jenne. Kyle Jenne is Chief Commercial Officer in AKCEA THERAPEUTICS, INC. ($AKCA).
Latest Insider Trading Transactions of Kyle Jenne
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.76 | 34,200 | 436,392 | 0 | |
Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 17.38 | 13,701 | 238,123 | 0 | |
Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 17.38 | 299 | 5,197 | 0 | |
Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.21 | 32,751 | 399,890 | 0 | |
Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.21 | 143,374 | 1,750,597 | 0 | |
Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Sell | U | 18.15 | 52,012 | 944,018 | 0 | 52 K to 0 (-100.00 %) |
Sep 24 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Sell | S | 18.12 | 720 | 13,046 | 52,012 | 52.7 K to 52 K (-1.37 %) |
Mar 25 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Sell | S | 11.75 | 779 | 9,153 | 52,732 | 53.5 K to 52.7 K (-1.46 %) |
Mar 23 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | A | 12.76 | 34,200 | 436,392 | 34,200 | |
Mar 23 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Grant | A | 0.00 | 16,800 | 0 | 53,511 | 36.7 K to 53.5 K (+45.76 %) |
Oct 23 2019 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | A | 18.94 | 50,000 | 947,000 | 50,000 | |
Oct 23 2019 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Grant | A | 0.00 | 25,000 | 0 | 36,711 | 11.7 K to 36.7 K (+213.47 %) |
Page: 1